You have free access to this content

CNS Neuroscience & Therapeutics

Cover image for Vol. 16 Issue 2

April 2010

Volume 16, Issue 2

Pages 61–124

  1. EDITORIAL

    1. Top of page
    2. EDITORIAL
    3. ANXIETY
    4. PAEDIATRICS
    5. VISION AND NEURODEGENERATION
    6. REVIEW
    1. You have free access to this content
  2. ANXIETY

    1. Top of page
    2. EDITORIAL
    3. ANXIETY
    4. PAEDIATRICS
    5. VISION AND NEURODEGENERATION
    6. REVIEW
    1. You have free access to this content
    2. You have free access to this content
      The Prevalence of Migraine Headaches in an Anxiety Disorders Clinic Sample (pages 76–82)

      Rhandi Senaratne, Michael Van Ameringen, Catherine Mancini, Beth Patterson and Mark Bennett

      Version of Record online: 5 MAR 2010 | DOI: 10.1111/j.1755-5949.2009.00103.x

  3. PAEDIATRICS

    1. Top of page
    2. EDITORIAL
    3. ANXIETY
    4. PAEDIATRICS
    5. VISION AND NEURODEGENERATION
    6. REVIEW
    1. You have free access to this content
    2. You have free access to this content
      A Prospective Open-Label Trial of Lamotrigine Monotherapy in Children and Adolescents with Bipolar Disorder (pages 91–102)

      Joseph Biederman, Gagan Joshi, Eric Mick, Robert Doyle, Anna Georgiopoulos, Paul Hammerness, Meghan Kotarski, Courtney Williams and Janet Wozniak

      Version of Record online: 5 MAR 2010 | DOI: 10.1111/j.1755-5949.2009.00121.x

  4. VISION AND NEURODEGENERATION

    1. Top of page
    2. EDITORIAL
    3. ANXIETY
    4. PAEDIATRICS
    5. VISION AND NEURODEGENERATION
    6. REVIEW
    1. You have free access to this content
      Lomerizine, a Ca2+ Channel Blocker, Protects against Neuronal Degeneration within the Visual Center of the Brain after Retinal Damage in Mice (pages 103–114)

      Yasushi Ito, Shinsuke Nakamura, Hirotaka Tanaka, Kazuhiro Tsuruma, Masamitsu Shimazawa, Makoto Araie and Hideaki Hara

      Version of Record online: 24 SEP 2009 | DOI: 10.1111/j.1755-5949.2009.00081.x

  5. REVIEW

    1. Top of page
    2. EDITORIAL
    3. ANXIETY
    4. PAEDIATRICS
    5. VISION AND NEURODEGENERATION
    6. REVIEW
    1. You have free access to this content
      Hyperbaric Oxygen Therapy for Multiple Sclerosis (pages 115–124)

      Michael Bennett and Robert Heard

      Version of Record online: 5 MAR 2010 | DOI: 10.1111/j.1755-5949.2009.00129.x

SEARCH

SEARCH BY CITATION